Edwards Lifesciences Corp. engages in the patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into three areas: Transcatheter Heart ...

Wedgewood Partners, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the letter ...

Edwards Lifesciences Corporation (EW), headquartered in Irvine, California, is a company that specializes in innovative ...

Fintel reports that on January 16, 2025, Wolfe Research downgraded their outlook for Edwards Lifesciences (NYSE:EW) from Peer ...

CASE ALLEGATIONS: Edwards Lifesciences provides products and technologies for structural heart disease and critical care monitoring. One of Edward Lifesciences' core products is Transcatheter ...

Edwards Lifesciences EW, following the sell-off of the Critical Care wing, looks forward to developing the most comprehensive structural heart portfolio. In TMTT, the robust adoption of the ...

Capital Investment Advisors LLC lowered its stake in shares of Edwards Lifesciences Co. (NYSE:EW – Free Report) by 2.4% during the fourth quarter, according to its most recent disclosure with the ...

Zacks Research raised their FY2024 earnings per share (EPS) estimates for Edwards Lifesciences in a research note issued on ...

In September, the company completed a $4.2 billion acquisition of Edwards Lifesciences’ Critical Care product group – which is being renamed as BD Advanced Patient Monitoring. “Today ...

Edwards Lifesciences Corp. engages in patient-focused medical innovations for heart disease and critical care monitoring. Its products are categorized into four main areas: Transcatheter Aortic ...